Price $60.70 |
Market Cap
3.03B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
5.2
|
P/B
2.88
|
P/S
2.88
|
Dividend %
-
|
|
P/CF
18.7
|
P/FCF
5.4
|
Op. Cash Flow
595.7K
|
FCF
18.4
|
|
Op. Margin
72.30%
|
Net Margin
55.00%
|
ROE
68.60%
|
ROI
36.50%
|
|
ROA
57.60%
|
EPS Growth
842.90%
|
Current Ratio
4.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Avanos Medical Inc (AVNS) | $31.44 | - | - | 1.66B | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.37 | - | - | 48.8M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.19 | - | - | 29.3M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.19 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
